Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 35

Trial Status

Completed8
Other1

Role Distribution

Principal Investigator1
Other Roles8
PI Rate11%

Activity Timeline

Clinical Trials (9)

Research Network

Collaboration Network

40 collaborators·51 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dawn Hershman, MD

Herbert Irving Comprehensive Cancer Center

Moderately Similar
7 trials

Shared therapeutic areas:

Breast CancerPainHypercalcemia of Malignancy+1 more

Worked with same sponsors:

National Cancer Institute (NCI)NCIC Clinical Trials Group+2 more
Collaborated on 1 trial
Similarity Score44%

Saul E. Rivkin, MD

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus

Moderately Similar
1 trials

Shared therapeutic areas:

Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Collaborated on 1 trial
Similarity Score44%

Anne F. Schott, MD

University of Michigan Rogel Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Breast CancerMetastatic CancerPain

Worked with same sponsors:

National Cancer Institute (NCI)SWOG Cancer Research Network
Collaborated on 1 trial
Similarity Score34%

Lori J. Goldstein, MD

Fox Chase Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Breast CancerInfertilityMenopausal Symptoms

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score34%

Robert C. Miller, MD

Mayo Clinic

Moderately Similar
6 trials

Shared therapeutic areas:

PainBreast CancerLung Cancer

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+5 more
Collaborated on 1 trial
Similarity Score34%

Ann H. Partridge, MD, MPH

Dana-Farber Cancer Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Breast CancerInfertilityMenopausal Symptoms

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+3 more
Collaborated on 1 trial
Similarity Score34%

Kelly-Anne Phillips

Peter MacCallum Cancer Centre, Australia

Moderately Similar
3 trials

Shared therapeutic areas:

Breast CancerInfertilityMenopausal Symptoms

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+3 more
Collaborated on 1 trial
Similarity Score34%

Halle C Moore, MD

The Cleveland Clinic

Moderately Similar
2 trials

Shared therapeutic areas:

Breast CancerInfertilityMenopausal Symptoms

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+3 more
Collaborated on 1 trial
Similarity Score34%

Silvana Martino, DO

Saint John's Cancer Institute

Moderately Similar
4 trials

Shared therapeutic areas:

Breast CancerInfertilityMenopausal Symptoms

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+5 more
Collaborated on 1 trial
Similarity Score34%

Edith A. Perez, MD

Mayo Clinic

Related
18 trials

Shared therapeutic areas:

Breast CancerLung Cancer

Worked with same sponsors:

Cancer and Leukemia Group BEastern Cooperative Oncology Group+4 more
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT00014222Phase 3StudyChair

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Breast Cancer
Completed
NCT00002550Phase 3PrincipalInvestigator

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Lung Cancer
Completed
NCT00068601Phase 3StudyChair

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Breast CancerInfertilityMenopausal Symptoms
Completed
NCT00087152Phase 2StudyChair

S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer

Breast Cancer
Completed
NCT00107276Phase 2StudyChair

S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer

Breast Cancer
Completed
NCT00301886Phase 3StudyChair

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
Withdrawn
NCT00450281StudyChair

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Lung Cancer
Completed
NCT00897091StudyChair

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Breast Cancer
Completed
NCT00929591Phase 3StudyChair

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Breast Cancer
Completed

All 9 trials loaded